GGrantIndex
← Leaderboards

Ruogang Zhao

State University Of New York At Buffalo

$4,781,783
Attributed
$5,673,823
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,673,823 · 4

By mechanism

R01$4,760,475 · 3
R33$913,348 · 1

Top collaborators

Most similar at State University Of New York At Buffalo

Same institution · by research overlap

Others in their field

Top investigators on “Fibrosis

Research focus

FibrosisInnovationCellsIn VitroMechanicsTransforming Growth Factor BetaResearch PersonnelLungAnimalsTissuesIn Vitro ModelDesignPulmonary FibrosisFda ApprovedClinical TrialsFibroblastsPharmaceutical PreparationsPhysiologicalDevicesDisease ProgressionAdoptedMembraneCostCessation Of Life

Grant awards (13)

Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$603,501
R01 · FY2025 · CA · contact PI
Modeling pulmonary fibrosis progression caused by differential mechanical stretch$393,689
R01 · FY2025 · HL · contact PI
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$570,048
R01 · FY2024 · CA · contact PI
Modeling pulmonary fibrosis progression caused by differential mechanical stretch$393,788
R01 · FY2024 · HL · contact PI
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$610,531
R01 · FY2023 · CA · contact PI
Modeling pulmonary fibrosis progression caused by differential mechanical stretch$393,885
R01 · FY2023 · HL · contact PI
Modeling pulmonary fibrosis progression caused by differential mechanical stretch$387,869
R01 · FY2022 · HL · contact PI
An inflammation-induced fibrosis-on-chip system for the testing of anti-fibrosis drugs$452,381
R33 · FY2021 · HL · contact PI
An inflammation-induced fibrosis-on-chip system for the testing of anti-fibrosis drugs$460,967
R33 · FY2020 · HL · contact PI
Fibrotic microtissue chips for screening of anti-fibrotic therapies$348,937
R01 · FY2018 · EB · contact PI
Fibrotic microtissue chips for screening of anti-fibrotic therapies$352,500
R01 · FY2017 · EB · contact PI
Fibrotic microtissue chips for screening of anti-fibrotic therapies$352,745
R01 · FY2016 · EB · contact PI
Fibrotic microtissue chips for screening of anti-fibrotic therapies$352,982
R01 · FY2015 · EB · contact PI